Rekvina Laboratories Ltd

NSE: VINRKLB · BSE: 526075 · Pharmaceuticals & Biotechnology · 22 announcements

Share price: ₹51.51
Market cap: ₹31.05 Cr
Revenue (annual): ₹1.27 Cr
Net profit (annual): ₹-0.25 Cr
P/E (TTM): -91.4×Sector 47.4×
Promoter holding: 77.00%+35.70% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 5 Management Change 3 Financial Results 3 Annual General Meeting 3 Open Offer 2 Board Meeting Date 2 Price Movement Clarification 1 Merger & Restructuring 1 Capital Structure Change 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

12 Aug 2026 17:27 IST BSE

Merger & Restructuring

Rekvina Laboratories Merger & Restructuring Worth ₹5.09 Cr

Rekvina Laboratories allotted 50,87,750 equity shares on a preferential basis, aggregating ₹5.09 Crore, to acquire Radiant Parenterals Limited as a wholly-owned subsidiary.

Value: ₹5.09 Cr

Read the filing ↗